The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Cytogenetic Prognostication Within Medulloblastoma Subgroups
Open accessAbstract
Purpose: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent of resection, and histologic variant. Stark prognostic and genetic differences among the four subgroups suggest that subgroup-specific molecular biomarkers could improve patient prognostication. Patients and Methods: Molecular biomarkers were identified from a discovery set of 673 medulloblastomas from 43 cities around the world. Combined risk stratification models were designed based on clinical and cytogenetic biomarkers identified by multivariable Cox proportional hazards analyses. Identified biomarkers were tested using fluorescent in situ hybridization (FISH) on a nonoverlapping medulloblastoma tissue microarray (n = 453), with subsequent validation of the risk stratification models. Results: Subgroup information improves the predictive accuracy of a multivariable survival model compared with clinical biomarkers alone. Most previously published cytogenetic biomarkers are only prognostic within a single medulloblastoma subgroup. Profiling six FISH biomarkers (GLI2, MYC, chromosome 11 [chr11], chr14, 17p, and 17q) on formalin-fixed paraffin-embedded tissues, we can reliably and reproducibly identify very low-risk and very high-risk patients within SHH, Group 3, and Group 4 medulloblastomas. Conclusion: Combining subgroup and cytogenetic biomarkers with established clinical biomarkers substantially improves patient prognostication, even in the context of heterogeneous clinical therapies. The prognostic significance of most molecular biomarkers is restricted to a specific subgroup. We have identified a small panel of cytogenetic biomarkers that reliably identifies very high-risk and very low-risk groups of patients, making it an excellent tool for selecting patients for therapy intensification and therapy de-escalation in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936 · cited 3×
“DISCUSSION Current consensus identifies the existence of four major subgroups of medulloblastoma, with excellent prognosis for those with WNT tumors, intermediate prognosis for those with SHH and Group 4 tumors, and poor prognosis for those with Group 3 tumors.(32,52) However, early evidence suggests clinical heteroge…”
BackgroundSelf-citationMedulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,339
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citationGajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L. E., Merchant, T. E., Woo, S., Wheeler, G., Ahern, V., Krasin, M. J., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70867-1 · Cited by 951
Self-citationSubgroup-specific structural variation across 1,000 medulloblastoma genomes
Northcott, P. A., Shih, D. J. H., Peacock, J., Garzia, L., Sorana Morrissy, A., Zichner, T., Stütz, A. M., Korshunov, A., Reimand, J., Schumacher, S. E., et al. (2012) · Nature · doi:10.1038/nature11327 · Cited by 899
Self-citationRausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Self-citationNovel mutations target distinct subgroups of medulloblastoma
Robinson, G., Parker, M., Kranenburg, T. A., Lu, C., Chen, X., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 846
Self-citationDissecting the genomic complexity underlying medulloblastoma
Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · Nature · doi:10.1038/nature11284 · Cited by 839
Self-citationSubtypes of medulloblastoma have distinct developmental origins
Gibson, P., Tong, Y., Robinson, G., Thompson, M. C., Currle, D. S., Eden, C., Kranenburg, T. A., Hogg, T., Poppleton, H., Martin, J., et al. (2010) · Nature · doi:10.1038/nature09587 · Cited by 831
Self-citationMedulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature · doi:10.1038/nature11329 · Cited by 750
Self-citationKool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 722
Self-citationThe Genetic Landscape of the Childhood Cancer Medulloblastoma
Parsons, D. W., Li, M., Zhang, X., Jones, S., Leary, R. J., Lin, J. C.-H., Boca, S. M., Carter, H., Samayoa, J., Bettegowda, C., et al. (2011) · Science · doi:10.1126/science.1198056 · Cited by 717
Self-citationCho, Y.-J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5148 · Cited by 717
Self-citationGenomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., Chintagumpala, M., Adesina, A., Ashley, D. M., Kellie, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4974 · Cited by 668
Self-citationMedulloblastomics: the end of the beginning
Northcott, P. A., Jones, D. T. W., Kool, M., Robinson, G. W., Gilbertson, R. J., Cho, Y.-J., Pomeroy, S. L., Korshunov, A., Lichter, P., Taylor, M. D., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3410 · Cited by 663
Self-citationMedulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., Kenney, A. M., Brat, D. J., Perry, A., Yong, W. H., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0800-8 · Cited by 563
Self-citationEllison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., Pearson, A. D., & Clifford, S. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5479 · Cited by 435
Self-citationNorthcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
Self-citationRapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Northcott, P. A., Shih, D. J. H., Remke, M., Cho, Y.-J., Kool, M., Hawkins, C., Eberhart, C. G., Dubuc, A., Guettouche, T., Cardentey, Y., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0899-7 · Cited by 382
Self-citationLannering, B., Rutkowski, S., Doz, F., Pizer, B., Gustafsson, G., Navajas, A., Massimino, M., Reddingius, R., Benesch, M., Carrie, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8719 · Cited by 333
Self-citationThe clinical implications of medulloblastoma subgroups
Northcott, P. A., Korshunov, A., Pfister, S. M., & Taylor, M. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.78 · Cited by 328
Self-citationEllison, D. W., Kocak, M., Dalton, J., Megahed, H., Lusher, M. E., Ryan, S. L., Zhao, W., Nicholson, S. L., Taylor, R. E., Bailey, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2810 · Cited by 302
Self-citationPfister, S., Remke, M., Benner, A., Mendrzyk, F., Toedt, G., Felsberg, J., Wittmann, A., Devens, F., Gerber, N. U., Joos, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9432 · Cited by 293
Self-citationClifford, S. C., Lusher, M. E., Lindsey, J. C., Langdon, J. A., Gilbertson, R. J., Straughton, D., & Ellison, D. W. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3446 · Cited by 270
Self-citationAdult Medulloblastoma Comprises Three Major Molecular Variants
Remke, M., Hielscher, T., Northcott, P. A., Witt, H., Ryzhova, M., Wittmann, A., Benner, A., von Deimling, A., Scheurlen, W., Perry, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.9373 · Cited by 258
Self-citationCastelo-Branco, P., Choufani, S., Mack, S., Gallagher, D., Zhang, C., Lipman, T., Zhukova, N., Walker, E. J., Martin, D., Merino, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70110-4 · Cited by 250
Self-citationExpression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.
Segal, R. A., Goumnerova, L. C., Kwon, Y. K., Stiles, C. D., & Pomeroy, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12867 · Cited by 241
Self-citationPediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Northcott, P. A., Hielscher, T., Dubuc, A., Mack, S., Shih, D., Remke, M., Al-Halabi, H., Albrecht, S., Jabado, N., Eberhart, C. G., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0846-7 · Cited by 226
Self-citationEberhart, C. G., Kratz, J., Wang, Y., Summers, K., Stearns, D., Cohen, K., Dang, C. V., & Burger, P. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.441 · Cited by 218
Self-citationMendrzyk, F., Radlwimmer, B., Joos, S., Kokocinski, F., Benner, A., Stange, D. E., Neben, K., Fiegler, H., Carter, N. P., Reifenberger, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8589 · Cited by 213
Self-citationCombined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients
Lamont, J. M., McManamy, C. S., Pearson, A. D., Clifford, S. C., & Ellison, D. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0721 · Cited by 209
Self-citationMolecular subgroups of medulloblastoma
Northcott, P. A., Dubuc, A. M., Pfister, S., & Taylor, M. D. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.66 · Cited by 187
Self-citationPrognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
Gilbertson, R. J., Perry, R., Kelly, P. J., Pearson, A. D. J., & Lunec, J. (1997) · PubMed · doi:10.25405/ncl.34590669 · Cited by 185
ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma.
Hernán, R., Fasheh, R., Calabrese, C. R., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., & Gilbertson, R. J. (2003) · PubMed · Cited by 185
Schwalbe, E. C., Williamson, D., Lindsey, J. C., Hamilton, D., Ryan, S. L., Megahed, H., Garami, M., Hauser, P., Dembowska-Baginska, B., Perek, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1077-2 · Cited by 178
Self-citationEdelstein, K., Spiegler, B. J., Fung, S., Panzarella, T., Mabbott, D., Jewitt, N. C., D’Agostino, N. M., Mason, W. P., Bouffet, É., Tabori, U. Y., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor015 · Cited by 176
Self-citationFSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
Remke, M., Hielscher, T., Korshunov, A., Northcott, P. A., Bender, S., Kool, M., Westermann, F., Benner, A., Cin, H., Ryzhova, M. V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2798 · Cited by 169
Self-citationClinical and molecular stratification of disease risk in medulloblastoma
Gilbertson, R., Wickramasinghe, C., Hernan, R., Balaji, V, Hunt, D., Jones-Wallace, D., Crolla, J., Perry, R., Lunec, J., Pearson, A., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1987 · Cited by 168
Korshunov, A., Remke, M., Werft, W., Benner, A., Ryzhova, M., Witt, H., Sturm, D., Wittmann, A., Schöttler, A., Felsberg, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7121 · Cited by 161
Self-citationUniversal Poor Survival in Children With Medulloblastoma Harboring Somatic TP53 Mutations
Tabori, U. Y., Baskin, B., Shago, M., Alon, N., Taylor, M. D., Ray, P. N., Bouffet, É., Malkin, D. M., & Hawkins, C. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5952 · Cited by 154
Self-citationPalmer, S. L., Hassall, T., Evankovich, K. D., Mabbott, D., Bonner, M. J., Deluca, C., Cohn, R. J., Fisher, M. J., Morris, E. B., Broniscer, A., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq094 · Cited by 148
Self-citationOTX2 Is Critical for the Maintenance and Progression of Shh-Independent Medulloblastomas
Adamson, D. C., Shi, Q., Wortham, M., Northcott, P. A., Di, C., Duncan, C. G., Li, J., McLendon, R. E., Bigner, D. D., Taylor, M. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2331 · Cited by 145
Self-citationPrognostic implications of chromosome 17p deletions in human medulloblastomas
Batra, S. K., McLendon, R. E., Koo, J. S., Castelino‐Prabhu, S., Fuchs, H. E., Krischer, J. P., Friedman, H. S., Bigner, D. D., & Bigner, S. H. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01052657 · Cited by 134
Ryan, S. L., Schwalbe, E. C., Cole, M. F., Lu, Y., Lusher, M. E., Megahed, H., O’Toole, K., Nicholson, S. L., Bognár, L., Garami, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0923-y · Cited by 113
Self-citationPrognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma
Gilbertson, R. J., Pearson, A., Perry, R. H., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.96 · Cited by 109
Pfaff, E., Remke, M., Sturm, D., Benner, A., Witt, H., Milde, T., von Bueren, A. O., Wittmann, A., Schöttler, A., Jorch, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1670 · Cited by 107
Self-citationMolecular diagnostics of CNS embryonal tumors
Pfister, S. M., Korshunov, A., Kool, M., Hasselblatt, M., Eberhart, C. G., & Taylor, M. D. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0751-5 · Cited by 89
Self-citationIsochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma Patients
Pan, E., Pellarin, M., Holmes, E., Smirnov, I. V., Misra, A., Eberhart, C. G., Burger, P. C., Biegel, J. A., & Feuerstein, B. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0465 · Cited by 89
Self-citationBiological and clinical heterogeneity of MYCN-amplified medulloblastoma
Korshunov, A., Remke, M., Kool, M., Hielscher, T., Northcott, P. A., Williamson, D., Pfaff, E., Witt, H., Jones, D., Ryzhova, M. V., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0918-8 · Cited by 86
Self-citationMorgan, J. (1884) · The Lancet · doi:10.1016/s0140-6736(02)02524-2 · Cited by 83
Rapid Diagnosis of Medulloblastoma Molecular Subgroups
Schwalbe, E. C., Lindsey, J. C., Straughton, D., Hogg, T. L., Cole, M. F., Megahed, H., Ryan, S. L., Lusher, M. E., Taylor, M. D., Gilbertson, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2210 · Cited by 81
Self-citationThe Genetics of Pediatric Brain Tumors
Dubuc, A. M., Northcott, P. A., Mack, S. C., Witt, H., Pfister, S. M., & Taylor, M. D. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0103-9 · Cited by 79
Self-citationRamaswamy, V., Northcott, P. A., & Taylor, M. D. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.11.001 · Cited by 70
Self-citationImpact of Radiation Avoidance on Survival and Neurocognitive Outcome in Infant Medulloblastoma
Lafay‐Cousin, L., Bouffet, É., Hawkins, C. E., Amid, A., Huang, A., & Mabbott, D. (2009) · Current Oncology · doi:10.3747/co.v16i6.435 · Cited by 67
Self-citationGenomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
Northcott, P. A., Rutka, J. T., & Taylor, M. D. (2009) · Neurosurgical FOCUS · doi:10.3171/2009.10.focus09218 · Cited by 58
Self-citationPark, A. K., Lee, S., Phi, J. H., Wang, K.-C., Kim, D. G., Cho, B.-K., Haberler, C., Fattet, S., Dufour, C., Puget, S., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor196 · Cited by 53
Self-citationSubgroup-specific alternative splicing in medulloblastoma
Dubuc, A. M., Morrissy, A. S., Kloosterhof, N. K., Northcott, P. A., Yu, E. P. Y., Shih, D. J. H., Peacock, J., Grajkowska, W., Meter, T. E. V., Eberhart, C. G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0959-7 · Cited by 31
Self-citationMYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma
Bourdeaut, F., Grison, C., Maurage, C., Laquerrière, A., Vasiljevic, A., Delisle, M., Michalak, S., Figarella‐Branger, D., Doz, F., Richer, W., et al. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.02.003 · Cited by 17
Self-citationBien-Willner, G. A., Lopez-Terrada, D. H., Bhattacharjee, M., Patel, K., Stankiewicz, P., Lupski, J. R., Pfeifer, J. D., & Perry, A. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos086 · Cited by 14
Cited by
The whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
“Still, considerable molecular and clinical heterogeneity has been demonstrated 11,40 , suggesting that currently defined MB subgroups are likely to be an oversimplification of true molecular substructure.”
Self-citationRisk stratification of childhood medulloblastoma in the molecular era: the current consensus
Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S. C., Doz, F., Kool, M., Dufour, C., Vassal, G., Milde, T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1569-6 · Cited by 654
Self-citationNorthcott, P. A., Robinson, G. W., Kratz, C. P., Mabbott, D. J., Pomeroy, S. L., Clifford, S. C., Rutkowski, S., Ellison, D. W., Malkin, D., Taylor, M. D., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0063-6 · Cited by 649
Self-citationSchwalbe, E. C., Lindsey, J. C., Nakjang, S., Crosier, S., Smith, A. J., Hicks, D., Rafiee, G., Hill, R. M., Iliasova, A., Stone, T., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30243-7 · Cited by 516
Self-citationRobinson, G. W., Orr, B. A., Wu, G., Gururangan, S., Lin, T., Qaddoumi, I., Packer, R. J., Goldman, S., Prados, M. D., Desjardins, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.1591 · Cited by 448
Self-citation
Metadata
- Authors
- Shih, D. J. H., Northcott, P. A., Remke, M., Korshunov, A., Ramaswamy, V., Kool, M., Luu, B., Yao, Y., Wang, X., Dubuc, A. M., Garzia, L., Peacock, J., Mack, S. C., Wu, X., Rolider, A., Morrissy, A. S., Cavalli, F. M. G., Jones, D. T. W., Zitterbart, K., Faria, C. C., Schüller, U., Kren, L., Kumabe, T., Tominaga, T., Shin Ra, Y., Garami, M., Hauser, P., Chan, J. A., Robinson, S., Bognár, L., Klekner, A., Saad, A. G., Liau, L. M., Albrecht, S., Fontebasso, A., Cinalli, G., De Antonellis, P., Zollo, M., Cooper, M. K., Thompson, R. C., Bailey, S., Lindsey, J. C., Di Rocco, C., Massimi, L., Michiels, E. M. C., Scherer, S. W., Phillips, J. J., Gupta, N., Fan, X., Muraszko, K. M., Vibhakar, R., Eberhart, C. G., Fouladi, M., Lach, B., Jung, S., Wechsler-Reya, R. J., Fèvre-Montange, M., Jouvet, A., Jabado, N., Pollack, I. F., Weiss, W. A., Lee, J.-Y., Cho, B.-K., Kim, S.-K., Wang, K.-C., Leonard, J. R., Rubin, J. B., de Torres, C., Lavarino, C., Mora, J., Cho, Y.-J., Tabori, U., Olson, J. M., Gajjar, A., Packer, R. J., Rutkowski, S., Pomeroy, S. L., French, P. J., Kloosterhof, N. K., Kros, J. M., Van Meir, E. G., Clifford, S. C., Bourdeaut, F., Delattre, O., Doz, F. F., Hawkins, C. E., Malkin, D., Grajkowska, W. A., Perek-Polnik, M., Bouffet, E., Rutka, J. T., Pfister, S. M., & Taylor, M. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-03-20
- Volume
- 32
- Issue
- 9
- Pages
- 886-896
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2099920119
- Cited by
- 313
- References
- 59
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.